Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Treatment of Acute Heart Failure.
Pediatric Critical Care Medicine · 2016-03-01 · Guideline / consensus
Abstract
OBJECTIVES: To provide an evidence-based review of pharmacotherapies to treat acute heart failure. To accomplish this objective, we will discuss circulatory physiology, vasoactive agents, and their indications in the management of acute heart failure. DATA SOURCE: A MEDLINE-baseline review of the literature. CONCLUSIONS: The optimal selection of vasoactive agents requires a consideration of circulatory physiology and the tailored application of pharmacotherapies to treat patients with acute heart failure.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Cardiovascular drugs · Vasopressors · Children
Related articles
- Early diagnosis and treatment of acute heart failure in prehospital and emergency settings. Part 1 of the International Expert Opinion Series on acute heart failure management. (Eur J Emerg Med, 2025)
- Acute heart failure - an EFIM guideline critical appraisal and adaptation for internists. (Eur J Intern Med, 2024)
- 2019 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces. (Circulation, 2019)
- The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion. (Int J Cardiol, 2016)
- Updated American College of Critical Care Medicine--pediatric advanced life support guidelines for management of pediatric and neonatal septic shock: relevance to the emergency care clinician. (Pediatr Emerg Care, 2010)
- Management of Acute Heart Failure during an Early Phase. (Int J Heart Fail, 2020)